Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).

Xue Li Kuan Peng Franco W T Cheng David C L Lam Ching Lung Cheung Celine S L Chui Francisco T T Lai Eric Y F Wan Carlos K H Wong Tiantian Ma Samson H H Yum Esther W Y Chan Jian Dong Huang Chak Sing Lau Mary S M Ip Ian C K Wong

J Infect

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong; Laboratory of Data Discovery for Health (D(2)4H), Hong Kong Science Park, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, Hong Kong. Electronic address:

Published: March 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758065	PMC
http://dx.doi.org/10.1016/j.jinf.2022.12.016	DOI Listing

Publication Analysis

Top Keywords

tuberculosis two-dose

two-dose sars-cov-2

sars-cov-2 vaccination

vaccination messenger

messenger rna

rna vaccine

vaccine bnt162b2

bnt162b2 inactivated

inactivated virus

virus vaccine

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!